Showing results (751-760 of 1,699) with videos related to
Sort By:
Pageof 170
Plos One|August 14, 2008
A Semantic Web management model for integrative biomedical informaticsHelena F Deus, Romesh Stanislaus, Diogo F Veiga, et al.Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015
KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.The American Journal of Pathology|June 19, 2016
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical ActivityMarina Cardó-Vila, Serena Marchiò, Masanori Sato, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.BMC Genomics|December 10, 2014
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSteven H Lin, Jing Wang, Pierre Saintigny, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerYang Xie, Wei Lu, Shidan Wang, et al.The Journal of Pathology|May 15, 2018
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patientsElena Martínez-Terroba, Carmen Behrens, Fernando J de Miguel, et al.Journal of Bronchology & Interventional Pulmonology|August 3, 2019
Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory StudyHoriana B Grosu, Wei Lu, David E Ost, et al.Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.Pageof 170